A look at ITeos Therapeutics Inc’s (ITOS) recent performance gives investors their first glimpse of hope.

On Friday, ITeos Therapeutics Inc (NASDAQ: ITOS) opened lower -4.26% from the last session, before settling in for the closing price of $15.50. Price fluctuations for ITOS have ranged from $8.20 to $18.75 over the past 52 weeks.

Healthcare Sector giant saw their annual sales slid by -23.53% over the last five years. Company’s average yearly earnings per share was noted -34.48% at the time writing. With a float of $27.68 million, this company’s outstanding shares have now reached $35.84 million.

The firm has a total of 157 workers. Let’s measure their productivity.

ITeos Therapeutics Inc (ITOS) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ITeos Therapeutics Inc is 23.37%, while institutional ownership is 74.51%. The most recent insider transaction that took place on Oct 12 ’23, was worth 41,850. In this transaction Chief Financial Officer of this company bought 5,000 shares at a rate of $8.37, taking the stock ownership to the 19,429 shares. Before that another transaction happened on Aug 23 ’23, when Company’s sold 350,000 for $16.26, making the entire transaction worth $5,692,673. This insider now owns 1,804,058 shares in total.

ITeos Therapeutics Inc (ITOS) Earnings and Forecasts

If we go through the results of last quarter, which was made public on 3/31/2024, the company posted -0.96 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.03) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.04 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -34.48% per share during the next fiscal year.

ITeos Therapeutics Inc (NASDAQ: ITOS) Trading Performance Indicators

Check out the current performance indicators for ITeos Therapeutics Inc (ITOS). In the past quarter, the stock posted a quick ratio of 13.51.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.78, a number that is poised to hit -1.04 in the next quarter and is forecasted to reach -5.11 in one year’s time.

Technical Analysis of ITeos Therapeutics Inc (ITOS)

Analysing the last 5-days average volume posted by the [ITeos Therapeutics Inc, ITOS], we can find that recorded value of 0.51 million was better than the volume posted last year of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 35.26%. Additionally, its Average True Range was 0.76.

During the past 100 days, ITeos Therapeutics Inc’s (ITOS) raw stochastic average was set at 56.80%, which indicates a significant increase from 20.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.52% in the past 14 days, which was lower than the 78.78% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $14.88, while its 200-day Moving Average is $11.73. Now, the first resistance to watch is $15.60. This is followed by the second major resistance level at $16.36. The third major resistance level sits at $16.87. If the price goes on to break the first support level at $14.33, it is likely to go to the next support level at $13.82. Should the price break the second support level, the third support level stands at $13.06.

ITeos Therapeutics Inc (NASDAQ: ITOS) Key Stats

There are currently 36,123K shares outstanding in the company with a market cap of 536.02 million. Presently, the company’s annual sales total 12,600 K according to its annual income of -112,640 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -38,220 K.